vers la météo de la validation par utilisateur

Ingenuity289


precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 72 - PMID ?

In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :

Analyse 0
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                                   
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 1
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                                   
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 2
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 3
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 4
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 5
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 6
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 7
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 8
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                                   
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 9
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 10
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 11
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 12
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 13
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 14
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 15
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 16
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 17
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 18
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 19
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 20
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 21
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

Analyse 22
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 23
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

Analyse 24
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

Analyse 25
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 26
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

Analyse 27
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 28
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 29
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 30
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 31
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 32
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 33
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 34
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 35
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 36
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 37
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 38
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 39
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 40
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 41
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 42
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 43
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 44
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

Analyse 45
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 46
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 47
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 48
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 49
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 50
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 51
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 52
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 53
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

Analyse 54
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 55
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 56
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 57
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 58
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 59
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 60
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 61
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 62
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 63
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 64
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 65
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 66
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 67
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 68
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 69
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 70
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 71
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 72
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

Analyse 73
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 74
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

Analyse 75
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 76
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 77
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 78
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 79
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 80
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                                   
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 81
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 82
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                                   
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 83
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 84
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 85
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 86
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 87
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 88
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 89
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 90
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 91
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 92
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 93
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 94
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 95
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 96
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 97
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 98
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 99
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 100
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 101
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)

Analyse 102
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 103
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)

Analyse 104
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 105
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V-N--------------+     |                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 106
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 107
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 108
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 109
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V-N--------------+     |                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

Analyse 110
                                                                                                                                   +------------------------------------COMP:V-N(by)------------------------------------+     
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V-N--------------+     |            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)

Analyse 111
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 112
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 113
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+---------COMP:N-N(by)--------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 114
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 115
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 116
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 117
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+---------COMP:N-N(by)--------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 118
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 119
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 120
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 121
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)

Analyse 122
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 123
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)

Analyse 124
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 125
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 126
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 127
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+---------COMP:N-N(by)--------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 128
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 129
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 130
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 131
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

Analyse 132
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +-------------COMP:N-N(by)------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 133
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                              +-------------COMP:N-N(by)------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 134
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-----------------COMP:N-N(by)----------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 135
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                      +-----------------COMP:N-N(by)----------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 136
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +-------------COMP:N-N(by)------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 137
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                              +-------------COMP:N-N(by)------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 138
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-----------------COMP:N-N(by)----------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 139
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                      +-----------------COMP:N-N(by)----------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 140
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 141
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 142
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 143
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 144
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 145
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 146
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 147
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 148
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +-------------COMP:N-N(by)------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 149
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                              +-------------COMP:N-N(by)------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 150
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +-------------COMP:N-N(by)------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 151
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                              +-------------COMP:N-N(by)------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 152
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+          +-----------------COMP:N-N(by)----------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 153
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 154
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

Analyse 155
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)